Technical Specifications; Warranty/Service - Beurer IH 24 Kids Instructions For Use Manual

Hide thumbs Also See for IH 24 Kids:
Table of Contents

Advertisement

Available languages
  • EN

Available languages

  • ENGLISH, page 16
13. TECHNICAL
SPECIFICATIONS
Model
IH 24 Kids
Dimensions
(W x H x D)
150 x 210 x 150 mm
Weight
1.28 kg
Operating
pressure
Approx. 0.8 to 1.55 bar
Atomiser filling
Max. 8 ml
volume
Min. 2 ml
Medication
flow rate
Approx. 0.35 ml/min
Sound
Approx. 52 dBA
pressure
(according to DIN EN 27427
Section 26)
Mains
230 V~; 50 Hz; 230 VA
connection
UK: 240 V~; 50 Hz; 240 VA
Saudi Arabia: 220 V~; 60 Hz;
220 VA
Operating
Temperature: +10 °C to +40 °C
conditions
Relative humidity: 10% to 95%
Ambient pressure: 700 hPa to
1060 hPa
Storage and
Temperature: -25 °C to +70 °C
transportation
Relative humidity: 10% to 95%
conditions
Ambient pressure: 700 hPa to
1060 hPa
Aerosol
1) Aerosol delivery: 0.11 ml
performance
2) Aerosol delivery rate:
according to
0.07 ml/min
EN27427:2019
3) Fill volume dispensed in
based on adult
percent per min.: 3.5%
ventilatory
4) Residual volume: 1.68 ml
pattern with
5) Particle size (MMAD): 3.07 µm
sodium
6) GSD (geometrical standard
fluoride (NaF):
deviation): 2.03
7) RF (Respirable fraction
< 5 μm): 75%
8) Large particle range (>5 μm):
25%
9) Medium particle range (2 to
5 μm): 47.8%
10) Small particle range (<2 μm):
27.2%
The serial number is located on the device or in
the battery compartment.
Subject to technical changes.
Particle size diagram
Measurements were performed using a sodium
fluoride solution with a "Next Generation
Impactor" (NGI).
The diagram may therefore not be applicable to
suspensions or highly viscous medications. You
can obtain more detailed information from the
manufacturer of your medication.

14. WARRANTY/SERVICE

Further information on the warranty and warranty
conditions can be found in the warranty leaflet
supplied.
Notification of incidents
For users/patients in the European Union and
identical regulation systems (EU Medical Device
Regulation (MDR) 2017/745), the following
applies: If during or through use of the product
a major incident occurs, notify the manufacturer
and/or their representative of this as well as the
respective national authority of the member state
in which the user/patient is located.
26

Advertisement

Table of Contents
loading

Table of Contents